期刊文献+

注射用丹参多酚酸盐治疗慢性肾衰竭疗效分析 被引量:7

下载PDF
导出
摘要 目的:观察注射用丹参多酚酸盐治疗慢性肾衰竭中的疗效。方法:64例随机数字表法分为对照组和观察组各32例。两组均采用常规口服药物治疗,观察组加用丹参多酚酸盐注射治疗,治疗2周后比较两组肾功能。结果:两组尿素氮、血肌酐均较本组治疗前下降(P<0.05),内生肌酐清除率较前明显升高(P<0.05),治疗后观察组尿素氮、血肌酐水平明显低于对照组(P<0.05),内生肌酐清除率明显高于对照组(P<0.05)。结论:注射用丹参多酚酸盐可以保护肾功能,延缓慢性肾衰竭的进展。 Objective : To observe the clinical effect of Salvianolate Injection in the treatment of chronic renal failure. Method: 64 cases with chronic renal failure were randomly divided into control group ( n=32 ) and observation group ( n=32 ) . Both groups were treated with conventional oral drugs and the observation group were treated with Salvianolate Injection additionally. After two weeks treatment, renal function between the two groups of patients was compared. Result: After two weeks of treatment, the urea nitrogen, serum creatinine of the two groups were both decreased compared with that before treatment and endogenous creatinine clearance rate was significantly higher than before. The level of urea nitrogen, serum creatinine of the observation group after the treatment was obviously lower than that of the control group while the endogenous creatinine clearance of the observation group after the treatment was significantly higher than that of the control group. The difference was statistically significant ( P〈0.05 ) .Conclusion: Salvianolate Injection could protect renal function and delay the progression of chronic renal failure.
作者 陈晨
出处 《实用中医药杂志》 2016年第11期1051-1052,共2页 Journal of Practical Traditional Chinese Medicine
关键词 慢性肾衰竭 丹参多酚酸盐 对照治疗观察 Chronic renal failure Salvianolate Injection Control treatment and observation
  • 相关文献

参考文献4

二级参考文献31

  • 1王稳,徐标.丹参多酚酸盐对健康人血小板内皮型一氧化氮合酶活性的影响[J].中华高血压杂志,2007,15(7):554-556. 被引量:19
  • 2Fine LG, Norman JT. Chronic hypoxia as a mechanism of progres- sion of chronic kidney diseases: from hypothesis to novel therapeu-ties[J]. Kidney Int, 2008, 74(1 ) :867-872.
  • 3Eckardt KU, Rosenberger C, Jurgensen JS, et al. Role of hypoxia in the pathogenesis of renal disease [ J ]. Kidney Int Suppl, 2005, 68(Supp 99) :S46-S51.
  • 4Massaomi N. Chronic hypoxia and tubuiointerstitial injury: A final common pathway to end stage renal failure [J].J Am Soc Nephrol, 2006, 17(1) :17-25.
  • 5Eddy AA. Molecular basis of renal fibrosis[J]. Pediatr Nepbrol, 2000,15 ( 3-4 ) :290-30 1.
  • 6I Szabo A J, Wagner L, Erdely A, et al. Renal neurnnal nitric oxide synthase protein expression as a marker of renal injury [ J ]. Kidney Int, 2003,64(5 ) : 1765-1771.
  • 7Deng A, Tang T, Singh P, et al. Regulation of oxygen utihzation by angiotensin Ⅱ in chronic kidney disease[ J ]. Kidney int, 2009, 75 (2) : 197-204.
  • 8林善炎,中华医学杂志,1992年,72卷,4期,201页
  • 9Yokozawa T,J Pharm Pharmacol,1990年,42卷,10期,712页
  • 10Yokozawa T,Chem Pharm Bull,1988年,36卷,1期,316页

共引文献131

同被引文献124

引证文献7

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部